The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer

AbstractEsophageal resection in patients with esophageal cancer (EC) is still associated with high mortality and morbidity rates. We aimed to develop a simple preoperative risk score for the prediction of short-term and long-term outcomes for patients with EC treated by esophageal resection.In total, 498 patients suffering from esophageal carcinoma, who underwent esophageal resection, were included in this retrospective cohort study. Three preoperative esophagectomy risk (PER) groups were defined based on preoperative functional evaluation of different organ systems by validated tools (revised cardiac risk index, model for end-stage liver disease score, and pulmonary function test). Clinicopathological parameters, morbidity, and mortality as well as disease-free survival (DFS) and overall survival (OS) were correlated to the PER score.The PER score significantly predicted the short-term outcome of patients with EC who underwent esophageal resection. PER 2 and PER 3 patients had at least double the risk of morbidity and mortality compared to PER 1 patients. Furthermore, a higher PER score was associated with shorter DFS (P < 0.001) and OS (P < 0.001). The PER score was identified as an independent predictor of tumor recurrence (hazard ratio [HR] 2.1; P < 0.001) and OS (HR 2.2; P < 0.001).The PER score allows preoperative objective allocation of patients with EC into different risk categories for morbidity, mortality, and long-term outcomes. Thus, multicenter studies are needed for independent validation of the PER score.

[1]  H. Gritsch,et al.  Revised Cardiac Risk Index (RCRI) Is a Useful Tool for Evaluation of Perioperative Cardiac Morbidity in Kidney Transplant Recipients , 2013, Transplantation.

[2]  T. Folliguet,et al.  Use of the model for end-stage liver disease score for guiding clinical decision-making in the selection of patients for emergency cardiac transplantation. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  D. McMillan,et al.  The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients , 2013, BMC Cancer.

[4]  H. Shimoji,et al.  Induction Chemotherapy or Chemoradiotherapy Followed by Radical Esophagectomy for T4 Esophageal Cancer: Results of a Prospective Cohort Study , 2013, World Journal of Surgery.

[5]  K. Sakamoto,et al.  Glasgow Prognostic Score as a Prognostic Factor in Patients Undergoing Curative Surgery for Colorectal Cancer , 2013, Digestive Surgery.

[6]  M. Quante,et al.  Experience Since MELD Implementation: How Does the New System Deliver? , 2012, International journal of hepatology.

[7]  T. Misawa,et al.  The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases. , 2012, Oncology letters.

[8]  J. Byrne,et al.  Risk Assessment Using a Novel Score to Predict Anastomotic Leak and Major Complications after Oesophageal Resection , 2012, Journal of Gastrointestinal Surgery.

[9]  M. Santhosh,et al.  A look into Lee's score: peri-operative cardiovascular risk assessment in non-cardiac surgeries-usefulness of revised cardiac risk index. , 2012, Indian heart journal.

[10]  D. Talwar,et al.  A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. , 2011, European journal of cancer.

[11]  C. Bodian,et al.  Indication for surgery, the revised cardiac risk index, and 1-year mortality. , 2011, Annals of vascular surgery.

[12]  J. Richer,et al.  Management of esophageal adenocarcinoma. , 2011, Journal of visceral surgery.

[13]  J. Izbicki,et al.  Glasgow Prognostic Score is a Predictor of Perioperative and Long-term Outcome in Patients with only Surgically Treated Esophageal Cancer , 2011, Annals of Surgical Oncology.

[14]  M. Morita,et al.  In-Hospital Mortality After a Surgical Resection for Esophageal Cancer: Analyses of the Associated Factors and Historical Changes , 2011, Annals of Surgical Oncology.

[15]  S. Harris,et al.  Revised cardiac risk index and postoperative morbidity after elective orthopaedic surgery: a prospective cohort study. , 2010, British journal of anaesthesia.

[16]  C. Compton,et al.  TNM seventh edition: What's new, what's changed , 2010, Cancer.

[17]  E. Steyerberg,et al.  Outcome of esophagectomy for cancer in elderly patients. , 2010, The Annals of thoracic surgery.

[18]  H. Ishwaran,et al.  Cancer of the esophagus and esophagogastric junction , 2010, Cancer.

[19]  Inflammation-Based Prognostic Score and Number of Lymph Node Metastases Are Independent Prognostic Factors in Esophageal Squamous Cell Carcinoma , 2010, Digestive Surgery.

[20]  T. Chou,et al.  Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. , 2010, The Annals of thoracic surgery.

[21]  D. Wijeysundera,et al.  Systematic Review: Prediction of Perioperative Cardiac Complications and Mortality by the Revised Cardiac Risk Index , 2010, Annals of Internal Medicine.

[22]  Kaoru Kobayashi,et al.  Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma. , 2008, Surgery.

[23]  S. D. de Castro,et al.  Evaluation of O‐POSSUM in predicting in‐hospital mortality after resection for oesophageal cancer , 2007, The British journal of surgery.

[24]  C. Earle,et al.  Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  R. Adams,et al.  Model for End-Stage Liver Disease (MELD) Predicts Nontransplant Surgical Mortality in Patients With Cirrhosis , 2005, Annals of surgery.

[26]  D. Prytherch,et al.  Risk‐adjusted prediction of operative mortality in oesophagogastric surgery with O‐POSSUM , 2004, The British journal of surgery.

[27]  J. Earnshaw,et al.  The Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM) , 2003, The British journal of surgery.

[28]  I. Martin,et al.  Evaluation of POSSUM in patients with oesophageal cancer undergoing resection , 2002, The British journal of surgery.

[29]  J. Siewert,et al.  Risk analysis in esophageal surgery. , 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[30]  H. Stein,et al.  Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer , 1998, The British journal of surgery.

[31]  O. Beahrs The American Joint Committee on Cancer. , 1984, Bulletin of the American College of Surgeons.

[32]  G. Onstad,et al.  Aminopyrine Breath Test Predicts Surgical Risk for Patients with Liver Disease , 1983, Annals of surgery.